These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37833984)

  • 21. Increase of blood-brain barrier leakage is related to cognitive decline in vascular mild cognitive impairment.
    Li M; Li Y; Zuo L; Hu W; Jiang T
    BMC Neurol; 2021 Apr; 21(1):159. PubMed ID: 33858381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. White matter microstructural damage and depressive symptoms in patients with mild cognitive impairment and cerebral small vessel disease: the VMCI-Tuscany Study.
    Pasi M; Poggesi A; Salvadori E; Diciotti S; Ciolli L; Del Bene A; Marini S; Nannucci S; Pescini F; Valenti R; Ginestroni A; Toschi N; Mascalchi M; Inzitari D; Pantoni L
    Int J Geriatr Psychiatry; 2016 Jun; 31(6):611-8. PubMed ID: 26489377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. White matter microstructural damage in small vessel disease is associated with Montreal cognitive assessment but not with mini mental state examination performances: vascular mild cognitive impairment Tuscany study.
    Pasi M; Salvadori E; Poggesi A; Ciolli L; Del Bene A; Marini S; Nannucci S; Pescini F; Valenti R; Ginestroni A; Toschi N; Diciotti S; Mascalchi M; Inzitari D; Pantoni L;
    Stroke; 2015 Jan; 46(1):262-4. PubMed ID: 25395414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebral small vessel disease may worsen motor function, cognition, and mood in Parkinson's disease.
    Chen H; Wan H; Zhang M; Liu G; Wang X; Wang Z; Ma H; Pan Y; Feng T; Wang Y
    Parkinsonism Relat Disord; 2021 Feb; 83():86-92. PubMed ID: 33493785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural changes in the lobar regions of brain in cerebral small-vessel disease patients with and without cognitive impairment: An MRI-based study with automated brain volumetry.
    Liu C; Zhao L; Yang S; Luo Y; Zhu W; Zhu W; Shi L
    Eur J Radiol; 2020 May; 126():108967. PubMed ID: 32268244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired dynamic cerebral autoregulation is associated with the severity of neuroimaging features of cerebral small vessel disease.
    Liu Z; Ma H; Guo ZN; Wang L; Qu Y; Fan L; Liu X; Liu J; Zhu Y; Yang Y
    CNS Neurosci Ther; 2022 Feb; 28(2):298-306. PubMed ID: 34894087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tracer kinetic assessment of blood-brain barrier leakage and blood volume in cerebral small vessel disease: Associations with disease burden and vascular risk factors.
    Stringer MS; Heye AK; Armitage PA; Chappell F; Valdés Hernández MDC; Makin SDJ; Sakka E; Thrippleton MJ; Wardlaw JM
    Neuroimage Clin; 2021; 32():102883. PubMed ID: 34911189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microglial activation and blood-brain barrier permeability in cerebral small vessel disease.
    Walsh J; Tozer DJ; Sari H; Hong YT; Drazyk A; Williams G; Shah NJ; O'Brien JT; Aigbirhio FI; Rosenberg G; Fryer TD; Markus HS
    Brain; 2021 Jun; 144(5):1361-1371. PubMed ID: 34000009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cilostazol reduces blood brain barrier dysfunction, white matter lesion formation and motor deficits following chronic cerebral hypoperfusion.
    Edrissi H; Schock SC; Cadonic R; Hakim AM; Thompson CS
    Brain Res; 2016 Sep; 1646():494-503. PubMed ID: 27350079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations between left ventricular function, vascular function and measures of cerebral small vessel disease: a cross-sectional magnetic resonance imaging study of the UK Biobank.
    van Hout MJP; Dekkers IA; Westenberg JJM; Schalij MJ; Scholte AJHA; Lamb HJ
    Eur Radiol; 2021 Jul; 31(7):5068-5076. PubMed ID: 33409793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired functional network properties contribute to white matter hyperintensity related cognitive decline in patients with cerebral small vessel disease.
    Wang Y; Liu X; Hu Y; Yu Z; Wu T; Wang J; Liu J; Liu J
    BMC Med Imaging; 2022 Mar; 22(1):40. PubMed ID: 35264145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV infection and cerebral small vessel disease are independently associated with brain atrophy and cognitive impairment.
    Sanford R; Strain J; Dadar M; Maranzano J; Bonnet A; Mayo NE; Scott SC; Fellows LK; Ances BM; Collins DL
    AIDS; 2019 Jun; 33(7):1197-1205. PubMed ID: 30870193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. White matter hyperintensities mediate the association between blood-brain barrier leakage and information processing speed.
    Freeze WM; Jacobs HIL; de Jong JJ; Verheggen ICM; Gronenschild EHBM; Palm WM; Hoff EI; Wardlaw JM; Jansen JFA; Verhey FR; Backes WH
    Neurobiol Aging; 2020 Jan; 85():113-122. PubMed ID: 31718926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneous white matter damage, cognitive decline and neuroinflammation in middle-aged hypertensive rats: an animal model of early-stage cerebral small vessel disease.
    Kaiser D; Weise G; Möller K; Scheibe J; Pösel C; Baasch S; Gawlitza M; Lobsien D; Diederich K; Minnerup J; Kranz A; Boltze J; Wagner DC
    Acta Neuropathol Commun; 2014 Dec; 2():169. PubMed ID: 25519173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epimedium flavonoids improve cognitive impairment and white matter lesions induced by chronic cerebral hypoperfusion through inhibiting the Lingo-1/Fyn/ROCK pathway and activating the BDNF/NRG1/PI3K pathway in rats.
    Niu HM; Wang MY; Ma DL; Chen XP; Zhang L; Li YL; Zhang L; Li L
    Brain Res; 2020 Sep; 1743():146902. PubMed ID: 32446949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T
    Brandhofe A; Stratmann C; Schüre JR; Pilatus U; Hattingen E; Deichmann R; Nöth U; Wagner M; Gracien RM; Seiler A
    J Cereb Blood Flow Metab; 2021 Jul; 41(7):1767-1777. PubMed ID: 33327818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal blood-brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI.
    Cramer SP; Simonsen H; Frederiksen JL; Rostrup E; Larsson HB
    Neuroimage Clin; 2014; 4():182-9. PubMed ID: 24371801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Predictors and integrative index of severity of cognitive disorders in cerebral microangiopathy].
    Dobrynina LA; Gadzhieva ZS; Shamtieva KV; Kremneva EI; Filatov AS; Bitsieva ET; Mirokova ED; Krotenkova MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(4):52-60. PubMed ID: 35485065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations of vitamin D deficiency with MRI markers of brain health in a community sample.
    Croll PH; Boelens M; Vernooij MW; van de Rest O; Zillikens MC; Ikram MA; Voortman T
    Clin Nutr; 2021 Jan; 40(1):72-78. PubMed ID: 32387186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spatiotemporal Dynamics of Cerebral Vascular Permeability in Type 2 Diabetes-Related Cerebral Microangiopathy.
    Chen YC; Lu BZ; Shu YC; Sun YT
    Front Endocrinol (Lausanne); 2021; 12():805637. PubMed ID: 35087478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.